World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
90
Citations
40962
World Ranking
12013
National Ranking
6158

Overview

Dennis J. Ahnen was affiliated with the University of Colorado Denver in the United States. Their main field of study was Medicine, with a focus on several subfields including Oncology, Pathology and Forensic Medicine, Cancer Research, Surgery, and Pharmacology.

Their research topics covered a range of subjects primarily related to colorectal and other gastrointestinal cancers. The main topics of their work included:

  • Genetic factors in colorectal cancer
  • Colorectal Cancer Screening and Detection
  • Cancer, Lipids, and Metabolism
  • Colorectal Cancer Treatments and Studies
  • Inflammatory mediators and NSAID effects
  • Colorectal and Anal Carcinomas
  • Gastric Cancer Management and Outcomes

Dennis J. Ahnen's publication record featured multiple recent papers with diverse research focuses. Notable papers included:

  • "Underutilization of Lynch Syndrome Screening at Two Large Veterans Affairs Medical Centers," 2020, published in Digestive Diseases and Sciences
  • "Proliferation, apoptosis and their regulatory protein expression in colorectal adenomas and serrated lesions," 2021, published in PLoS ONE
  • "Bariatric Surgery Is Associated with a Recent Temporal Increase in Colorectal Cancer Resections, Most Pronounced in Adults Below 50 Years of Age," 2020, published in Obesity Surgery
  • "Genetic Variations in SMAD7 Are Associated with Colorectal Cancer Risk in the Colon Cancer Family Registry," 2020, published in UNC Libraries
  • "Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive Tumors," 2020, published in UNC Libraries

Their work was published across various venues, with a significant number of publications appearing in UNC Libraries. Other frequent venues included PLoS ONE, Digestive Diseases and Sciences, Obesity Surgery, and JAMA Oncology.

Dennis J. Ahnen also collaborated extensively with several researchers. Frequent coauthors included:

  • John A. Baron
  • Robert W. Haile
  • John L. Hopper
  • Noralane M. Lindor
  • Daniel D. Buchanan

Best Publications

  • Colorectal cancer statistics, 2017.

    Rebecca L. Siegel;Kimberly D. Miller;Stacey A. Fedewa;Dennis J. Ahnen

  • Use of Colonoscopy to Screen Asymptomatic Adults for Colorectal Cancer

    David A. Lieberman;David G. Weiss;John H. Bond;Dennis J. Ahnen

  • A randomized trial of aspirin to prevent colorectal adenomas

    John A. Baron;Bernard F. Cole;Robert S. Sandler;Robert W. Haile

  • Helicobacter pylori in Peptic Ulcer Disease

    Tadataka Yamada;John G. Searle;Dennis Ahnen

  • Serrated Lesions of the Colorectum: Review and Recommendations From an Expert Panel

    Douglas K. Rex;Dennis J. Ahnen;John A. Baron;Kenneth P. Batts

  • Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial.

    Stuart Jon Spechler;Edward Lee;Dennis Ahnen;Raj K. Goyal

  • Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.

    Bernard F. Cole;John A. Baron;Robert S. Sandler;Robert W. Haile

  • A Pooled Analysis of Advanced Colorectal Neoplasia Diagnoses After Colonoscopic Polypectomy

    María Elena Martínez;John A. Baron;David A. Lieberman;Arthur Schatzkin

  • Identification of Lynch syndrome among patients with colorectal cancer

    Leticia Moreira;Francesc Balaguer;Noralane Lindor;Albert De La Chapelle

  • Antineoplastic Drugs Sulindac Sulfide and Sulfone Inhibit Cell Growth by Inducing Apoptosis

    Gary A. Piazza;Alanna L. Kulchak Rahm;Mary Krutzsch;Gerhard Sperl

  • Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: A randomized placebo-controlled, double-blind trial

    Frank L. Meyskens;Christine E. McLaren;Daniel Pelot;Sharon Fujikawa-Brooks

  • Apoptosis Primarily Accounts for the Growth-inhibitory Properties of Sulindac Metabolites and Involves a Mechanism That Is Independent of Cyclooxygenase Inhibition, Cell Cycle Arrest, and p53 Induction

    Gary A. Piazza;Alanna K. Rahm;Tyler S. Finn;Benjamin H. Fryer

  • Colorectal Cancer in Patients Under Close Colonoscopic Surveillance

    Douglas J. Robertson;Douglas J. Robertson;E. Robert Greenberg;Michael Beach;Robert S. Sandler

  • Five-year colon surveillance after screening colonoscopy.

    David A. Lieberman;David G. Weiss;William V. Harford;Dennis J. Ahnen

  • The Increasing Incidence of Young-Onset Colorectal Cancer: A Call to Action

    Dennis J. Ahnen;Sally W. Wade;Whitney F. Jones;Randa Sifri

  • Sulindac Sulfone Inhibits Azoxymethane-induced Colon Carcinogenesis in Rats without Reducing Prostaglandin Levels

    Gary A. Piazza;David S. Alberts;Lee J. Hixson;Nancy Shipp Paranka

  • Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer

    Aung Ko Win;Mark A. Jenkins;James G Dowty;Antonis C Antoniou

  • Colorectal cancers soon after colonoscopy: a pooled multicohort analysis

    Douglas J Robertson;David A Lieberman;Sidney J Winawer;Dennis J Ahnen

  • Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study.

    Dennis J. Ahnen;Polly Feigl;Gang Quan;Cecelia Fenoglio-Preiser

  • Urinary Metabolites of Prostanoids and Risk of Recurrent Colorectal Adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS)

    Veronika Fedirko;Patrick T. Bradshaw;Jane C. Figueiredo;Robert S. Sandler

Frequent Co-Authors

John A. Baron
John A. Baron University of North Carolina at Chapel Hill
Polly A. Newcomb
Polly A. Newcomb Fred Hutchinson Cancer Research Center
Robert W. Haile
Robert W. Haile Stanford University
Robert S. Sandler
Robert S. Sandler University of North Carolina at Chapel Hill
John D. Potter
John D. Potter Massey University
David A. Lieberman
David A. Lieberman Oregon Health & Science University
Daniel D. Buchanan
Daniel D. Buchanan University of Melbourne
John L. Hopper
John L. Hopper University of Melbourne
Mark A. Jenkins
Mark A. Jenkins University of Melbourne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a traditional MD in the USA isn’t the only pathway into the medical or healthcare field. Students interested in quicker career entry can consider fast track lpn programs online, which provide foundational nursing skills and faster job prospects.

For those looking for advanced practice within mental health, the fastest pmhnp program options offer a flexible route to become a psychiatric mental health nurse practitioner. These programs suit nursing graduates aiming to specialize and work with diverse patient populations.

If healthcare leadership or management is your goal, a health care administration online degree lets you build essential organizational and strategic skills. Many working professionals prefer this route for career advancement within hospitals, clinics, or insurance firms.

Budget-conscious learners can further explore the cheapest mha programs online, providing a graduate-level education without the hefty tuition fees. Each of these pathways supports different career ambitions, enabling broader access to healthcare careers beyond the traditional MD.

Best Scientists Citing Dennis J. Ahnen

Recently Published Articles